BRAVA Breast Expansion Device Reclassified by FDA
Posted April 19, 2013 in Breast, Breast LipoStructure, Coleman Technique for Fat Grafting, Fat Grafting Research
FDA asks for Investigational Device Exemption for BRAVA Studies The FDA, in a surprising move, has re-classified the BRAVA breast expansion device into a higher risk category for the ongoing BRAVA clinical trials. We want to assure our patients (those who are currently using the device, have used it in the past, or who contemplate […]
Read More